The overexpression of cyclin-dependent kinase (CDK) 2 in laryngeal squamous cell carcinomas

Anticancer Research

Volumn 21, Issue 1 A, 2001, Pages 103-108

  Dong, Y ^a   Sui, L ^a   Tai, Y ^a   Sugimoto, K ^a   Tokuda, M ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Cyclin dependent kinase; Larynx; Squamous cell carcinoma

Indexed keywords

CELL NUCLEUS ANTIGEN; CYCLIN DEPENDENT KINASE 2;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; CDC2-CDC28 KINASES; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN-SERINE-THREONINE KINASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0035060802     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Laryngeal cancer
2. Laryngeal cancer in Lower Silesia: Descriptive analysis of 501 cases
3. Mammalian G1 cyclins
4. Cyclins and cancer: IL Cyclin D and CDK inhibitors come of age
5. Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2
6. Principles of cdk regulation
7. Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle
8. G1 phase progression: Cyclins on cue
9. The retinoblastoma protein and cell cycle control
10. Cyclin E, a potential prognostic marker for breast cancer
11. Cyclins as markers of tumor proliferation: Immunocytochemical studies in breast cancer
12. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status
13. Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma
14. Role of p27Kipl and cyclindependent kinase 2 in the proliferation of non-small cell lung cancer
15. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas
16. Relevance of proliferative and pro-apoptotic factors in non- small-cell lung cancer for patient survival
17. Analysis of phosphorylation of pRB and its regulatory proteins in breast cancer
18. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma
19. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer
20. Amplified CDK2 and cdc2 activities in primary colorectal carcinoma
21. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
22. Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix
23. Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma
24. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta
25. Identity of the proliferating cell nuclear antigen and cyclin
26. Proliferating cell nuclear antigen in laryngeal cancer
27. p53, the cellular gatekeeper for growth and division
28. Cyclin dependent kinase regulation
29. Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors
30. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers
31. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells